BTIG maintains Atlassian at Buy, lowers price target to $240 from $260

BTIG kept its Buy rating on Atlassian but reduced its price target to $240 from $260, a 7.7% cut. The new target suggests a 30.9% upside from the Nov 5 close of $183.29. Recent analyst price targets for Atlassian range from $180 to $275.

Original reporting
Published Nov 6, 2026, 11:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BTIG maintains Atlassian at Buy, lowers price target to $240 from $260 — source image
Decision brief

The 30-second read

$TEAMBearishMed
01

Why it matters

The downgrade may influence short-term trading sentiment and trigger sell pressure.

02

Market read

Analyst target cuts are a common trigger for short-term price adjustments in tech stocks.

03

What to watch

Recent strong earnings beat and expanding cloud adoption are not reflected in the new target.

Relevance 6/10Novelty 6/10Timing: today

Background

BTIG analyst coverage on Atlassian includes a recent downgrade of the price target.

Company-level read

Ticker impact

$TEAMBearishHigh confidence
Context

BTIG lowered Atlassian's price target to $240 from $260, a 7.7% decrease.

Expected impact

potential downside pressure as the market prices in the lower target.

Evidence & confidence

Target reduction is a fresh analyst action that often precedes a short-term price pullback.

Market effects

May temper enthusiasm for enterprise software stocks in the short term.

Limited to U.S. and global tech investors.

Minor, as Atlassian is a single-company catalyst.

Counterpoint

The target cut could be overly cautious; recent product wins may support higher valuations.

Key entities

  • Atlassian

    Enterprise software provider listed on NASDAQ.

  • BTIG

    Equity research firm providing the price target revision.

Related articles

$TEAMMedAI 8/10

Atlassian Sinks 12% as Slower Growth Outlook Overshadows Beat: “Enterprise AI Has Hit an Inflection Point”

Atlassian (TEAM) shares fell 12% after guiding to 13.75% revenue growth for fiscal 2027, down from 24% last quarter. The slowdown is partly due to the planned wind-down of its Data Center software. The company beat earnings estimates for Q1, with revenue up 24% to $1.77 billion and adjusted EPS of $1.65. Analysts note the stock's P/E ratio is now 28x, below its 5-year average of 81x. Competitors monday.com (MNDY) and Salesforce (CRM) will report soon.